Evidence map›Paper›PMID 38390460›Full record

ArticleOpen forum infectious diseases2024

The Epidemiologic and Clinical Characteristics of the 2023 Dengue Outbreak in Bangladesh.

Nadim Sharif, Nazmul Sharif, Afsana Khan, Shuvra Kanti Dey

Registry-linked trialAbstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06744777 (The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06744777 phase3completednot on this map

The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever: A Double-blind, Randomized Control Trial

TypeinterventionalSponsorKhyber Medical University PeshawarRan2024 to 2025Enrolled284ConditionsDengue Fever, Dengue Hemorrhagic Fever, Severe DengueArmsRibavirin, Standard Treatment
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Dengue Cases in the Eastern Region of Afghanistan, 2021-2023.Journal of epidemiology and global health · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nadim SharifDepartment of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.ORCID https://orcid.org/0000-0003-2377-9726
Nazmul SharifDepartment of Mathematics, Rajshahi University of Engineering & Technology, Rajshahi, Bangladesh.
Afsana KhanDepartment of Statistics, Jahangirnagar University, Savar, Dhaka, Bangladesh.
Shuvra Kanti DeyDepartment of Microbiology, Jahangirnagar University, Savar, Dhaka, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ongoing 2023 dengue outbreak is the worst ever case reported in Bangladesh. There is a lack of epidemiological studies on the outbreak. A 2-tailed

Indexed as

Bangladeshclinical characteristicsdengueepidemiologyoutbreak

Identifiers

PMID38390460
PMCPMC10883285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.